Skip to main content

Featured

13 building plans approved in Nov

The Buildings Department approved 13 building plans in November - two on Hong Kong Island, six in Kowloon and five in the New Territories.   Of the approved plans, eight were for apartment and apartment-commercial developments, two for commercial developments, one for factory and industrial developments, and two for community services developments.   Consent was given for works to start on 11 building projects which will provide 210,471 sq m of gross floor area for domestic use involving 2,595 units and 83,060 sq m for non-domestic use.   Additionally, the department received notification of commencement of superstructure works for nine building projects.   The department also issued 16 occupation permits - three on Hong Kong Island, five in Kowloon and eight in the New Territories.   Buildings certified for occupation have 53,034 sq m of gross floor area for domestic use involving 1,355 units and 168,627 sq m for non-domestic use. http://dlvr.it/Sh3Dtw

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqH65

Popular Posts